vs
达美航空(DAL)与礼来(LLY)财务数据对比。点击上方公司名可切换其他公司
礼来的季度营收约是达美航空的1.2倍($19.3B vs $16.0B),礼来同比增速更快(42.6% vs 14.0%),过去两年礼来的营收复合增速更高(48.3% vs -2.0%)
达美航空是美国头部航空公司,总部位于佐治亚州亚特兰大,共设有9个航空枢纽,其中哈兹菲尔德-杰克逊亚特兰大国际机场是其客运量、出发班次最高的枢纽。旗下区域子公司及合作运营商以“达美连接”品牌运营,每日执飞超5400个航班,航线覆盖六大洲52个国家的325个目的地。
礼来(Eli Lilly and Company)是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业,1876年由美国内战时期联邦军退伍药剂师伊莱·礼来创立,目前在18个国家设有办事处,产品销往全球约125个国家,是全球知名的制药厂商。
DAL vs LLY — 直观对比
营收规模更大
LLY
是对方的1.2倍
$16.0B
营收增速更快
LLY
高出28.6%
14.0%
两年增速更快
LLY
近两年复合增速
-2.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $16.0B | $19.3B |
| 净利润 | — | $6.6B |
| 毛利率 | — | 82.5% |
| 营业利润率 | 9.2% | 42.8% |
| 净利率 | — | 34.4% |
| 营收同比 | 14.0% | 42.6% |
| 净利润同比 | — | 50.5% |
| 每股收益(稀释后) | $1.85 | $7.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DAL
LLY
| Q1 26 | $16.0B | — | ||
| Q4 25 | $16.0B | $19.3B | ||
| Q3 25 | $16.7B | $17.6B | ||
| Q2 25 | $16.6B | $15.6B | ||
| Q1 25 | $14.0B | $12.7B | ||
| Q4 24 | $15.6B | $13.5B | ||
| Q3 24 | $15.7B | $11.4B | ||
| Q2 24 | $16.7B | $11.3B |
净利润
DAL
LLY
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $6.6B | ||
| Q3 25 | $1.4B | $5.6B | ||
| Q2 25 | $2.1B | $5.7B | ||
| Q1 25 | $240.0M | $2.8B | ||
| Q4 24 | $843.0M | $4.4B | ||
| Q3 24 | $1.3B | $970.3M | ||
| Q2 24 | $1.3B | $3.0B |
毛利率
DAL
LLY
| Q1 26 | — | — | ||
| Q4 25 | — | 82.5% | ||
| Q3 25 | — | 82.9% | ||
| Q2 25 | — | 84.3% | ||
| Q1 25 | — | 82.5% | ||
| Q4 24 | — | 82.2% | ||
| Q3 24 | — | 81.0% | ||
| Q2 24 | — | 80.8% |
营业利润率
DAL
LLY
| Q1 26 | 9.2% | — | ||
| Q4 25 | 9.2% | 42.8% | ||
| Q3 25 | 10.1% | 41.1% | ||
| Q2 25 | 12.6% | 43.6% | ||
| Q1 25 | 4.1% | 27.2% | ||
| Q4 24 | 11.0% | 37.2% | ||
| Q3 24 | 8.9% | 13.9% | ||
| Q2 24 | 13.6% | 31.1% |
净利率
DAL
LLY
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | 34.4% | ||
| Q3 25 | 8.5% | 31.7% | ||
| Q2 25 | 12.8% | 36.4% | ||
| Q1 25 | 1.7% | 21.7% | ||
| Q4 24 | 5.4% | 32.6% | ||
| Q3 24 | 8.1% | 8.5% | ||
| Q2 24 | 7.8% | 26.3% |
每股收益(稀释后)
DAL
LLY
| Q1 26 | $1.85 | — | ||
| Q4 25 | $1.85 | $7.39 | ||
| Q3 25 | $2.17 | $6.21 | ||
| Q2 25 | $3.27 | $6.29 | ||
| Q1 25 | $0.37 | $3.06 | ||
| Q4 24 | $1.29 | $4.88 | ||
| Q3 24 | $1.97 | $1.07 | ||
| Q2 24 | $2.01 | $3.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.3B | $7.3B |
| 总债务越低越好 | $12.5B | — |
| 股东权益账面价值 | $20.9B | $26.5B |
| 总资产 | $81.3B | $112.5B |
| 负债/权益比越低杠杆越低 | 0.60× | — |
8季度趋势,按日历期对齐
现金及短期投资
DAL
LLY
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $7.3B | ||
| Q3 25 | $3.8B | $9.9B | ||
| Q2 25 | $3.3B | $3.5B | ||
| Q1 25 | $3.7B | $3.2B | ||
| Q4 24 | $3.1B | $3.4B | ||
| Q3 24 | $4.0B | $3.5B | ||
| Q2 24 | $4.2B | $3.4B |
总债务
DAL
LLY
| Q1 26 | $12.5B | — | ||
| Q4 25 | $12.5B | — | ||
| Q3 25 | $12.8B | — | ||
| Q2 25 | $12.8B | — | ||
| Q1 25 | $12.9B | — | ||
| Q4 24 | $14.0B | $29.5B | ||
| Q3 24 | $14.4B | — | ||
| Q2 24 | $15.0B | — |
股东权益
DAL
LLY
| Q1 26 | $20.9B | — | ||
| Q4 25 | $20.9B | $26.5B | ||
| Q3 25 | $18.8B | $23.8B | ||
| Q2 25 | $17.4B | $18.3B | ||
| Q1 25 | $15.4B | $15.8B | ||
| Q4 24 | $15.3B | $14.2B | ||
| Q3 24 | $13.6B | $14.2B | ||
| Q2 24 | $12.4B | $13.6B |
总资产
DAL
LLY
| Q1 26 | $81.3B | — | ||
| Q4 25 | $81.3B | $112.5B | ||
| Q3 25 | $79.6B | $114.9B | ||
| Q2 25 | $78.4B | $100.9B | ||
| Q1 25 | $77.3B | $89.4B | ||
| Q4 24 | $75.4B | $78.7B | ||
| Q3 24 | $75.4B | $75.6B | ||
| Q2 24 | $75.2B | $71.9B |
负债/权益比
DAL
LLY
| Q1 26 | 0.60× | — | ||
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.68× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.83× | — | ||
| Q4 24 | 0.92× | 2.08× | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | 1.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $3.2B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.49× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
DAL
LLY
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | $3.2B | ||
| Q3 25 | $1.8B | $8.8B | ||
| Q2 25 | $1.9B | $3.1B | ||
| Q1 25 | $2.4B | $1.7B | ||
| Q4 24 | $1.9B | $2.5B | ||
| Q3 24 | $1.3B | $3.7B | ||
| Q2 24 | $2.4B | $1.5B |
自由现金流
DAL
LLY
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | — | ||
| Q3 25 | $687.0M | — | ||
| Q2 25 | $648.0M | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $583.0M | — | ||
| Q3 24 | $-54.0M | — | ||
| Q2 24 | $1.1B | — |
自由现金流率
DAL
LLY
| Q1 26 | — | — | ||
| Q4 25 | 8.5% | — | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 8.2% | — | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | -0.3% | — | ||
| Q2 24 | 6.8% | — |
资本支出强度
DAL
LLY
| Q1 26 | — | — | ||
| Q4 25 | 5.7% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 8.5% | — | ||
| Q2 24 | 7.9% | — |
现金转化率
DAL
LLY
| Q1 26 | — | — | ||
| Q4 25 | 1.86× | 0.49× | ||
| Q3 25 | 1.30× | 1.58× | ||
| Q2 25 | 0.87× | 0.55× | ||
| Q1 25 | 9.91× | 0.60× | ||
| Q4 24 | 2.25× | 0.56× | ||
| Q3 24 | 1.00× | 3.83× | ||
| Q2 24 | 1.88× | 0.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAL
| Passenger Air Traffic | $10.8B | 67% |
| Product And Service Other Refinery | $1.7B | 10% |
| Product And Service Other Loyalty Program | $1.2B | 8% |
| Passenger Loyalty Travel Awards | $1.0B | 6% |
| Passenger Travel Related Services | $506.0M | 3% |
| Product And Service Other Ancillary Businesses | $380.0M | 2% |
| Cargo And Freight | $226.0M | 1% |
| Product And Service Other Miscellaneous | $71.0M | 0% |
LLY
| Other | $5.4B | 28% |
| Zepbound | $4.2B | 22% |
| Mounjaro | $4.1B | 21% |
| Verzenio | $997.1M | 5% |
| Collaborationand Other Revenue | $991.7M | 5% |
| Taltz | $724.3M | 4% |
| Trulicity | $692.8M | 4% |
| Other Cardiometabolic Health | $524.5M | 3% |
| Other Oncology | $514.8M | 3% |
| Jardiance | $465.8M | 2% |
| Neuroscience | $320.2M | 2% |
| Other Immunology | $187.3M | 1% |
| Other Product Total | $77.0M | 0% |